Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4238)
All Articles published online
|
Nov 14, 2005 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gad A, Tanaka E, Matsumoto A, Wahab MAE, Serwah AEH, Attia F, Ali K, Hassouba H, el-Deeb AER, Ichijyo T, Umemura T, Muto H, Yoshizawa K, Kiyosawa K. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(42): 6607-6612 [PMID: 16425352 DOI: 10.3748/wjg.v11.i42.6607] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i42/6607.htm |
| Number | Citing Articles |
| 1 |
Ryukou Izumi, Takahiko Matsushita, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Sakae Tsuda, Hiroshi Hinou, Shin‐Ichiro Nishimura. Microwave‐Assisted Solid‐Phase Synthesis of Antifreeze Glycopeptides. Chemistry – A European Journal 2013; 19(12): 3913 doi: 10.1002/chem.201203731
|
| 2 |
Hideto Kameda, Keiichiro Nishida, Toshihiro Nanki, Akira Watanabe, Yukiya Oshima, Shigeki Momohara. Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study. Modern Rheumatology 2024; 34(6): 1103 doi: 10.1093/mr/roae019
|
| 3 |
Takahiko Matsushita, Naoki Ohyabu, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Hiroshi Hinou, Shin-Ichiro Nishimura. Site-Specific Conformational Alteration Induced by Sialylation of MUC1 Tandem Repeating Glycopeptides at an Epitope Region for the Anti-KL-6 Monoclonal Antibody. Biochemistry 2013; 52(2): 402 doi: 10.1021/bi3013142
|
| 4 |
Tarek D. Hussein. Serological tumor markers of hepatocellular carcinoma: a meta-analysis. The International Journal of Biological Markers 2015; 30(1): 32 doi: 10.5301/jbm.5000119
|
| 5 |
Yugo Matsumura, Seidai Sato, Keiko Haji, Takeshi Masuda, Hiroto Yoneda, Hirokazu Ogino, Hirohisa Ogawa, Masaki Hanibuchi, Noboru Hattori, Yasuhiko Nishioka. A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6. Respiratory Medicine Case Reports 2024; 50: 102040 doi: 10.1016/j.rmcr.2024.102040
|
| 6 |
Takao Nagashima, Keisuke Saito, Yoshifumi Takahashi, Kojiro Sato. KL-6 as a Tumor Marker of Primary Peritoneal Cancer in Patients with Connective Tissue Diseases. Internal Medicine 2024; doi: 10.2169/internalmedicine.4366-24
|
| 7 |
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
|
| 8 |
Masahito Koiwa, Susumu Goto, Kenji Takenouchi, Kenji Takahasi, Toshikazu Kamada, Hiroshi Nakamura. Elevation of serum KL-6 levels in 3 patients with rheumatoid arthritis treated with adalimumab. Modern Rheumatology 2012; 22(1): 147 doi: 10.3109/s10165-011-0483-y
|
| 9 |
Tae Mogami, Haruya Saji, Naho Yokota, Rie Suzuki, Akiko Sukegawa, Mikiko Asai-Sato, Etsuko Miyagi, Fumiki Hirahara. Serum KL-6 for diagnosis of ovarian carcinoma associated with dermatomyositis: two case reports and characteristic clinicopathological factors. International Cancer Conference Journal 2012; 1(2): 83 doi: 10.1007/s13691-012-0016-3
|
| 10 |
Sandra M. Swain, Mizuki Nishino, Lisa H. Lancaster, Bob T. Li, Andrew G. Nicholson, Brian J. Bartholmai, Jarushka Naidoo, Eva Schumacher-Wulf, Kohei Shitara, Junji Tsurutani, Pierfranco Conte, Terufumi Kato, Fabrice Andre, Charles A. Powell. Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management. Cancer Treatment Reviews 2022; 106: 102378 doi: 10.1016/j.ctrv.2022.102378
|
| 11 |
Naoki Ohyabu, Hiroshi Hinou, Takahiko Matsushita, Ryukou Izumi, Hiroki Shimizu, Keiko Kawamoto, Yoshito Numata, Hiroko Togame, Hiroshi Takemoto, Hirosato Kondo, Shin-Ichiro Nishimura. An Essential Epitope of Anti-MUC1 Monoclonal Antibody KL-6 Revealed by Focused Glycopeptide Library. Journal of the American Chemical Society 2009; 131(47): 17102 doi: 10.1021/ja903361f
|
| 12 |
A. Seko, T. Ohkura, H. Ideo, K. Yamashita. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: Possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. Glycobiology 2012; 22(2): 181 doi: 10.1093/glycob/cwr118
|
| 13 |
Mona Abu El Makarem. An Overview of Biomarkers for the Diagnosis of Hepatocellular Carcinoma. Hepatitis Monthly 2012; 12(10 HCC) doi: 10.5812/hepatmon.6122
|
| 14 |
Linshun Xie, Yuting Cao, Futao Hu, Tianhua Li, Qiqin Wang, Ning Gan. Microfluidic chip electrophoresis for simultaneous fluorometric aptasensing of alpha-fetoprotein, carbohydrate antigen 125 and carcinoembryonic antigen by applying a catalytic hairpin assembly. Microchimica Acta 2019; 186(8) doi: 10.1007/s00604-019-3594-3
|
| 15 |
HONGYAN YUAN, JUAN WANG, FENGLI WANG, NANNAN ZHANG, QIONGSHU LI, FEI XIE, TANXIU CHEN, RUIPING ZHAI, FANG WANG, YINGYING GUO, WEIHUA NI, GUIXIANG TAI. Mucin 1 gene silencing inhibits the growth of SMMC-7721 human hepatoma cells through Bax-mediated mitochondrial and caspase-8-mediated death receptor apoptotic pathways. Molecular Medicine Reports 2015; 12(5): 6782 doi: 10.3892/mmr.2015.4323
|
| 16 |
Lorinda M. Wright, Jeff T. Kreikemeier, Claus J. Fimmel. A concise review of serum markers for hepatocellular cancer. Cancer Detection and Prevention 2007; 31(1): 35 doi: 10.1016/j.cdp.2006.11.003
|
| 17 |
Sho Sato, Tomomi Kato, Kenji Abe, Tatsuya Hanaoka, Yuri Yano, Akira Kurosaki, Masanori Yasuda, Tetsuo Sekino, Keiichi Fujiwara, Kosei Hasegawa. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression. Oncology Letters 2017; 14(1): 776 doi: 10.3892/ol.2017.6254
|
| 18 |
Kenji Nakahama, Motohiro Izumi, Naoki Yoshimoto, Mitsuru Fukui, Akira Sugimoto, Hiroaki Nagamine, Koichi Ogawa, Kenji Sawa, Yoko Tani, Hiroyasu Kaneda, Shigeki Mitsuoka, Tetsuya Watanabe, Kazuhisa Asai, Tomoya Kawaguchi. Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer. Cancer Chemotherapy and Pharmacology 2023; 92(5): 381 doi: 10.1007/s00280-023-04573-0
|
| 19 |
Ahmed M. Tahon, Magdy Z. El-Ghanam, Samy Zaky, Tarek Mostafa Emran, Ali M. Bersy, Fathiya El-Raey, Elsayed A.Z., Amr M. El Kharsawy, Dina Johar. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients. Journal of Gastrointestinal Cancer 2019; 50(3): 434 doi: 10.1007/s12029-018-0095-2
|
| 20 |
Aldona Kasprzak, Agnieszka Adamek. Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis. International Journal of Molecular Sciences 2019; 20(6): 1288 doi: 10.3390/ijms20061288
|
| 21 |
Shobith Rangappa, Gerard Artigas, Risho Miyoshi, Yasuhiro Yokoi, Shun Hayakawa, Fayna Garcia-Martin, Hiroshi Hinou, Shin-Ichiro Nishimura. Effects of the multiple O-glycosylation states on antibody recognition of the immunodominant motif in MUC1 extracellular tandem repeats. MedChemComm 2016; 7(6): 1102 doi: 10.1039/C6MD00100A
|